Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Conditions
- Relapsed/Refractory KMT2A-r Acute LeukemiaRelapsed/Refractory NUP98-r Acute LeukemiaRelapsed/Refractory NPM1-m Acute Leukemia
- Interventions
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- PedAL BCU, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT06376162
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇮🇹Fondazione IRCCS San Gerardo dei Tintori (Ospedale San Gerardo), Monza, Italy
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2025-10-15
- Lead Sponsor
- PedAL BCU, LLC
- Target Recruit Count
- 98
- Registration Number
- NCT05183035
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Conditions
- Myelodysplastic Syndrome Post Cytotoxic TherapyAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyMyelodysplastic SyndromeMyeloid Leukemia Associated With Down SyndromeMixed Phenotype Acute LeukemiaJuvenile Myelomonocytic Leukemia
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- PedAL BCU, LLC
- Target Recruit Count
- 960
- Registration Number
- NCT04726241
- Locations
- 🇺🇸
Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois, United States
🇺🇸Children's Hospital of Alabama, Birmingham, Alabama, United States
🇺🇸USA Health Strada Patient Care Center, Mobile, Alabama, United States
